Sustaining Associates

Sustaining Associate Members
Know Your Sustaining Associate Members

Abbott Laboratories
    Abbott Laboratories is one of the world’s leading health care companies, dedicated to improving people’s lives through the discovery, development, manufacture and marketing of health care products. Abbott invests well over $1 billion in internal research each year. The high productivity of this investment reinforces it as the primary component of the company’s growth strategy. Some of Abbott’s leading products are Biaxin, Depakote, Lupron, Survanta, Ensure, Similac, ProGibb, Ultane, AxSYM, and Precision QID.

ADInstruments
    ADInstruments manufactures a range of computer based data recorders for the life and physical sciences. The Maclab and Powerlab systems, comprising both hardware and software, record and display experimental data in real time, and features fast data manipulation, online computations, convenient file storage and high resolution data presentation. A range of signal conditioners and transducers extends the use of Powerlab into many specialist fields.

Eli Lilly and Company
    The Lilly Research Laboratories is dedicated to the advancement of basic scientific research upon which targeted medical breakthroughs may be identified. Eli Lilly and Company is committed to excellence in research as evidenced by a steadily increasing investment in novel “cutting edge” research methods and technology (e.g., genomics, combinatorial chemistry, and high volume screening) as they can be applied to drug discovery. Lilly scientists are focusing on basic research and targeted medical therapy for infectious diseases, cardiovascular disease, cancer, central nervous system disorders, and endocrine diseases, with an emphasis on obesity, diabetes, and osteoporosis.

The Gatorade Sports Science Institute
    Expertise in sports nutrition and exercise sciences is one of the unique and distinguishing attributes of The Gatorade Company. To further this expertise, the Gatorade Sports Science Institute was founded in the mid-1980’s to fully explore the role of fluid homeostasis and nutrient metabolism in exercise performance. Scientific research is conducted at the Gatorade Sports Science Institute and in cooperation with university researchers around the world. Gatorade employs exercise scientists who specialize in exercise physiology, biochemistry, and nutrition research. (Gatorade thirst quencher is the world leader in the sports drink category, and is made by The Gatorade Company, a wholly owned subsidiary of The Quaker Oats Company.)

Merck & Co., Inc.
    Merck & Co., Inc. is a worldwide, research-intensive company that discovers, develops, produces, and markets a broad range of human and animal health products and services. Merck’s product portfolio includes the cardiovascular drugs VASOTEC and PRINIVIL, and the cholesterol lowering drugs MEVACOR and ZOCOR, the gastrointestinal drug PEPCID, and for symptomatic benign prostate enlargement PROSCAR. Merck has recently introduced the antihypertensive drugs COZAAR and HYZAAR, the anti-glaucoma drug TRUSOPT, the HIV protease inhibitor CRIXIVAN for AIDS, the vaccines VARIVAX (protection against chickenpox and VAQTA (protection against hepatitis A), the osteoporosis drug FOSAMAX, and the over-the-counter antacid PEPCID AC.

Procter & Gamble Company
    Procter & Gamble is a multinational, consumer products and health care company committed to world-class research and product development. It has major technical centers in Cincinnati, OH; Norwich, NY; Hunt Valley, MD; Mexico City; Caracas, Venezuela; Brussels, Belgium; Egham and Newcastle, England; and Kobe, Japan.
The worldwide PhD population of P&G is over 1200, divided about equally between life scientists and chemists; total employees number 100,000.
    Sales in health care/pharmaceuticals, beauty care, cosmetics and fragrances, food and beverage, laundry and cleaning, and paper products make P&G one of the largest companies in the United States. Fortune magazine consistently recognizes P&G as one of the “Most Admired US Corporations.”

Rhône-Poulenc Rorer
    Rhône-Poulenc Rorer is an international company dedicated to health. RPR is the first pharmaceutical company in France, the third in Europe, with a turnover in 1994 of $4.5 billion: a research driven company with 14% reinvested in Research and Development ant 3,000 employees in R&D.
    With Research Centers located in France, USA and UK, Research & Development is focused on seven main therapeutic areas: oncology, cardiovascular diseases, infectious diseases/AIDS, rheumatology/bone metabolism, central nervous system disorders, respiratory diseases/allergies, plasma proteins.
    To invest in new technologies, gene and cell therapies, is the RPR’s commitment to the future.

G.D. Searle & Company
    The physiologic and scientific directions of Searle are primarily in areas related to arthritis and inflammation, cardiovascular disease and oncology, with an emphasis on adjunctive therapy and opportunistic infections. In these three major therapeutic areas, the emphasis is on defining new molecular targets that are likely to elicit a dramatic shift in therapeutic efficacy with a true ultimate enhancement of therapeutic benefit. Research employs high throughput robotic screening to define chemical or protein leads, medicinal chemistry and protein biochemistry including protein mutagenesis, to maximize the properties of the chemical or protein lead and extensive animal testing to determine proof of concept. Molecular and cell biology are utilized extensively to support screening efforts and to define the molecular targets underlying a particular disease, including the use of differential display PCR. The approach is to integrate expertise across scientific disciplines to rapidly determine proof of concept underlying a disease target.